Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

This study has been completed.
Sponsor:
Collaborator:
Hospitales Universitarios Virgen del Rocío
Information provided by (Responsible Party):
Hospital Universitario Central de Asturias
ClinicalTrials.gov Identifier:
NCT00761982
First received: September 28, 2008
Last updated: November 27, 2011
Last verified: November 2011